Chronic constipation: Let symptom type and severity direct treatment

Journal of Family Practice

Volumn 55, Issue 7, 2006, Pages 587-593

  Bleser, Scott D ^a  

^a Bellbrook Medical Center Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISACODYL; BULKING AGENT; CASCARA; IRON; ISPAGULA; LAXATIVE; LUBIPROSTONE; MACROGOL; MACROGOL 3350; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; METHYLCELLULOSE; OSMOTIC AGENT; POLYCARBOPHIL; RICINOLEIC ACID; SENNA EXTRACT; SEROTONIN 4 AGONIST; SODIUM DIHYDROGEN PHOSPHATE; TEGASEROD;

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ALLERGIC REACTION; ANOREXIA; BLOATING; BRAN; CALCIUM MALABSORPTION; CHRONIC CONSTIPATION; CHRONIC DISEASE; CLINICAL TRIAL; COLON INERTIA; CONSTIPATION; DEFECATION HABIT; DIARRHEA; DIETARY FIBER; DISEASE SEVERITY; DRUG CHOICE; DRUG INDICATION; ELECTROLYTE DISTURBANCE; EXERCISE; FECES IMPACTION; FLATULENCE; FLUID INTAKE; GASTRIC DYSMOTILITY; HIGH FIBER DIET; HUMAN; HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOVOLEMIA; INTESTINAL DYSMOTILITY; ISCHEMIC COLITIS; LIFESTYLE; LIVER TOXICITY; MALABSORPTION; PATIENT COUNSELING; PATIENT REFERRAL; PIGMENT DISORDER; PSEUDOMELANOSIS COLI; REVIEW; SYMPTOM;

ALPROSTADIL; CATHARTICS; CHRONIC DISEASE; CONSTIPATION; DIETARY FIBER; FATTY ACIDS; GASTROENTEROLOGY; GASTROINTESTINAL AGENTS; HUMANS; INDOLES; REFERRAL AND CONSULTATION;

EID: 33746031451     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Brandt LJ, Schoenfeld P, Prather CM, Quigley EMM, Schiller LR, Talley NJ. Evidenced-based position statement on the management of chronic constipation in North America. Am J Gastroenterol 2005; 100(suppl):S1-S21.
2. Schiller LR, Dennis E, Toth G. An internet-based survey of the prevalence and symptom spectrum of chronic constipation [abstract]. Am J Gastroenterol 2004; 99:3234.
3. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005; 100:936-971.
4. Pampati V, Fogel R. Treatment options for primary constipation. Curr Treat Options Gastroenterol 2004; 7:225-233.
5. Wald A. Constipation. Med Clin North Am 2000; 84:1231-1246.
6. Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci 1998; 43:2379-2383.
7. Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 1998; 45:727-732.
8. Locke GR, III, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterol 2000; 119:1766-1778.
9. Borum ML. Constipation: evaluation and management. Primary Care 2001; 28:577-590.
10. Talley NJ. Management of chronic constipation. Rev Gastroenterol Disord 2004; 4:18-24.
11. Locke GR, III, Pemberton JH, Phillips SF. AGA Medical Position Statement: guidelines on constipation. Gastroenterol 2000; 119:1761-1766.
12. Doughty DB. When fiber is not enough: current thinking on constipation management. Ostomy Wound Manage 2002; 48:30-41.
13. Cheskin LJ, Kamal N, Crowell MD, Schuster MM, Whitehead WE. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Genatr Soc 1995; 43:666-669.
14. Dukas L, Willett WC, Giovannucci EL. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol 2003; 98:1790-1796.
15. Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003; 349:1360-1368.
16. Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001; 44:1201-1209.
17. Schiller LR. Review article: the therapy of constipation. Aliment Pharmacol Ther 2001; 15:749-763.
18. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 2002; 47:2222-2230.
19. DiPalma JA. Current treatment options for chronic constipation. Rev Gastroenterol Disord 2004; (suppl 2):S34-S42.
20. Gattuso JM, Kamm MA. Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 1994; 10:47-65.
21. Tramonte SM, Brand MB, Mulrow CD, Amato MG, O'Keefe ME, Ramirez G. The treatment of chronic constipation in adults. A systematic review. J Gen Intern Med 1997; 12:15-24.
22. Petticrew M, Rodgers M, Booth A. Effectiveness of laxatives in adults. dual Health Care 2001; 10:268-273.
23. Zelnorm (tegaserod maleate) tablets [prescribing information]. East Hanover, NJ: Novartis; August 2004.
24. 4 receptor partial agonist with promotile activity. Clin Pharmacokinet 2002; 41:1021-1042.
25. Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004; 2:796-805.
26. Kamm MA, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: a randomized, double-Wind, placebo-controlled multinational study. Am J Gastroenterol 2005; 100:362-372.
27. Mueller-Lissner S, Kamm M, Haeck R et al. Long-term safety and tolerability of tegaserod in chronic constipation (CC) [abstract]. Gastroenterol 2004; 126(Suppl 2).
28. Schoenfeld P. Review article: the safety profile of tegaserod. Aliment Pharmacol Ther 2004; 20(suppl 7):25-30.
29. Joelsson BE, Shetzline MA, Cunningham S. Ischemic colitis associated with use of tegaserod [reply]. N Engl J Med 2004; 351:1363-1364.
30. Johanson JF, Gargano MA, Holland PC, Patchen ML, Ueno R. Phase III, randomized withdrawal study of RU-0211, a novel chloride channel activator for the treatment of constipation [abstract]. Gastroenterol 2004; 126(suppl 2):A100.
31. Johanson JF, Gargano MA, Holland PC, Patchen ML, Ueno R. Phase III efficacy and safety of RU-0211, a novel chloride channel activator, for the treatment of constipation [abstract]. Gastroenterol 2003; 124:A104.
32. Johanson JF, Gargano MA, Patchen ML, Ueno R. Efficacy and safety of a novel compound, RU-0211, for the treatment of constipation [abstract]. Gastroenterol 2002; 122:A-315.
33. Amitiza (lubiprostone) soft gelatin capsules [prescribing information]. Bethesda, Md: Sucampo Pharmaceuticals; 2006.
34. Schiller LR. New and emerging treatment options for chronic constipation. Rev Gastroenterol Dis 2004; 4:S43-S51.
35. Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci 1989; 34:606-611.
36. Dettmar PW, Sykes J. A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation. Curr Med Res Opin. 1998; 14:227-233.
37. Badiali D, Corazziari E, Habib Fl, et al. Effect of wheat bran in treatment of chronic nonorganic constipation: a double-blind controlled trial. Dig Dis Sci 1995; 40:349-356.
38. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998; 12:491-497.
39. Klauser AG, Muhldorfer BE, Voderholzer WA, Wenzel G, Muller-Lissner SA. Polyethylene glycol 4000 for slow transit constipation. Z Gastroenterol 1995; 33:5-8.
40. Cleveland MV, Flavin DP, Ruben RA, Epstein RM, Clark GE. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J 2001; 94:478-481.
41. Corazziari E, Badiali D, Bazzocchi G, et al. Long-term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000; 46:522-526.
42. Corazziari E, Badiali D, Habib Fl, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 1996; 41:1636-1642.